In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors
- PMID: 18539275
- DOI: 10.1016/j.fertnstert.2007.10.038
In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors
Abstract
Objective: To characterize the demographic correlates of IVF availability and utilization.
Design: Demographic analysis of public data.
Setting: Each of the 50 states in the United States was used as a unit of analysis.
Patient(s): Patients undergoing IVF, as demographically estimated.
Intervention(s): Publicly available data were collected through the Society for Assisted Reproductive Technology and the Centers for Disease Control. The US Census Bureau data were collected by using software available from the Centers for Disease Control.
Main outcome measure(s): The number of physicians performing IVF and the number of IVF cycles per 100,000 reproductive-age women were used to estimate IVF availability and utilization.
Result(s): In 2005, 1,031 providers performed 98,242 fresh IVF cycles in 430 centers. Overall availability was 2.5 IVF physicians per 100,000, and utilization was 236 IVF cycles per 100,000. Availability and utilization of IVF were highly correlated. Mean IVF availability and utilization were significantly higher in states with IVF insurance coverage. In adjusted analyses, IVF availability correlated positively with mandated insurance coverage, percentage of single persons, and median income. Utilization of IVF correlated with IVF availability, percentage urbanization, and percentage of individuals >or=25 years of age who had a bachelor's degree.
Conclusion(s): Lower rates of IVF utilization in some states are correlated with a lack of insurance coverage and decreased availability of physicians providing this service.
Similar articles
-
Insurance coverage and outcomes of in vitro fertilization.N Engl J Med. 2002 Aug 29;347(9):661-6. doi: 10.1056/NEJMsa013491. N Engl J Med. 2002. PMID: 12200554
-
Economic implications of insurance coverage for in vitro fertilization in the United States. A review.J Reprod Med. 2009 Nov-Dec;54(11-12):661-8. J Reprod Med. 2009. PMID: 20120898 Review.
-
Access to assisted reproductive technology centers in the United States.Fertil Steril. 2010 Feb;93(3):745-61. doi: 10.1016/j.fertnstert.2008.10.037. Epub 2008 Dec 10. Fertil Steril. 2010. PMID: 19081563
-
Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database.Fertil Steril. 2013 Aug;100(2):392-5. doi: 10.1016/j.fertnstert.2013.03.037. Epub 2013 Apr 23. Fertil Steril. 2013. PMID: 23623475
-
International disparities in access to infertility services.Fertil Steril. 2006 Apr;85(4):871-5. doi: 10.1016/j.fertnstert.2005.08.066. Fertil Steril. 2006. PMID: 16580367 Review.
Cited by
-
Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment.Reprod Biol Endocrinol. 2022 Aug 4;20(1):111. doi: 10.1186/s12958-022-00984-5. Reprod Biol Endocrinol. 2022. PMID: 35927756 Free PMC article. Review.
-
Mother or Father: Who Is in the Front Line? Mechanisms Underlying the Non-Genomic Transmission of Obesity/Diabetes via the Maternal or the Paternal Line.Nutrients. 2019 Jan 22;11(2):233. doi: 10.3390/nu11020233. Nutrients. 2019. PMID: 30678214 Free PMC article. Review.
-
Variability of essential and non-essential trace elements in the follicular fluid of women undergoing in vitro fertilization (IVF).Ecotoxicol Environ Saf. 2021 Feb;209:111733. doi: 10.1016/j.ecoenv.2020.111733. Epub 2020 Dec 29. Ecotoxicol Environ Saf. 2021. PMID: 33385679 Free PMC article.
-
Expensive but worth it: older parents' attitudes and opinions about the costs and insurance coverage for in vitro fertilization.Fertil Steril. 2012 Jan;97(1):82-7. doi: 10.1016/j.fertnstert.2011.10.019. Epub 2011 Nov 25. Fertil Steril. 2012. PMID: 22118993 Free PMC article.
-
Origins of lifetime health around the time of conception: causes and consequences.Lancet. 2018 May 5;391(10132):1842-1852. doi: 10.1016/S0140-6736(18)30312-X. Epub 2018 Apr 16. Lancet. 2018. PMID: 29673874 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources